The mechanisms by which HIV increases susceptibility to tuberculosis and other respiratory 37 infections are incompletely understood. We used transcriptomics of paired whole 38 bronchoalveolar lavage (BAL) fluid and peripheral blood mononuclear cells to compare the 39 effect of HIV at the lung mucosal surface and in the peripheral blood. The large majority of 40 HIV-induced differentially expressed genes (DEGs) were specific to either the peripheral or 41 lung mucosa compartments (1,307/1,404, 93%). Type I interferon signaling was the dominant 42 signature of DEGs in HIV-positive blood with a less dominant and qualitatively distinct type 43
Introduction
3 from the hospital-based cohort) ( Table 1 ). The median age of all participants was 34 years 105 and 50% of the participants were female. There were no significant differences in age or sex 106 distribution between the HIV-negative and HIV-positive groups. All HIV-infected 107 participants were ART-naïve. The median viral load for the HIV-infected group was 54,942 108 (Interquartile range [IQR]: 18, 293) . The median CD4+ T-cell counts for the uninfected and HIV-infected groups were 1,048 (IQR: 854-1,352) and 353 (IQR: 173-576), 110 respectively (p<0.0001). 111 112 Distribution of major immune cell populations in bronchoalveolar compartment and blood 113
To determine the HIV-specific effects on the distribution of major populations of immune 114 cells within each anatomical compartment, we used matched samples from the 115 bronchoalveolar compartment and blood to conduct two-way comparisons i.e. between 116 disease states within each compartment (comparisons 1 and 2, Figure 1A ) and between 117 compartments (comparisons 3 and 4). We carried out differential cell counts to enumerate 118 differences in distribution of key immune cell populations between the two compartments 119 ( Figure 1B) . In both HIV-negative and HIV-positive individuals, distributions of immune 120 cells were significantly different between the two compartments ( Figure 1C ). In both groups, 121 alveolar macrophages were the dominant immune cell in the bronchoalveolar compartment 122 with medians of 87.4% (Interquartile range [IQR]: 79.8-90) and 79.3 (Interquartile range 123
[IQR]: 70.9-88) among HIV-negative and HIV-positive persons, respectively ( Figure 1C and 124 Supplementary table 1) . On the other hand, lymphocytes and neutrophils were the dominant 125 immune cells in the peripheral blood in both groups. Notably, the distributions of major 126 participants within the compartments. 128
We then used flow cytometry to further assess if there were HIV-specific alterations within 129 the lymphocyte populations. The proportions of total T cells (CD3 + cells) were reduced in the 130 peripheral blood mononuclear cells (PBMCs) but increased in bronchoalveolar lavage fluid 131 cells (BLCs) of HIV-positive patients, consistent with HIV-associated T-cell infiltration in 132 bronchoalveolar compartment (p = 0.0030 and p=0.0473, respectively) ( Figure 1D ). The 133 reduction of proportions of CD3 + lymphocytes in PBMCs of HIV-positive study participants 134 was primarily due to the loss of CD4 + T cells as shown by the reduction in proportions of 135 CD4 + T cells in PBMCs (p =0.0001). We observed similar reduction in proportions of CD4 + 136 T cells in the BLCs of HIV-positive participants (p <0.0001) ( Figure 1E ). Notably, we 137 observed an HIV-associated increase in proportions of CD8 + T cells in both PBMCs (p = 138 0.002) and BLCs (p = <0.0001). In further separate analyses of the research bronchoscopy 139 cohort and the hospital-based cohort, we observed a similar HIV-associated increase in 140 proportions of CD8 + T cells and a reduction in proportions of CD4 + T cells in the BLCs and 141 PBMCs ( Supplementary figure 4 A, B , D and E). Thus, HIV was associated with an increase 142 in proportions of CD8 + T cells and a decrease in proportions of CD4 + T cells in both blood 143 and bronchoalveolar compartments in multiple cohorts. 144 145 HIV infection is associated with compartment-specific changes in the transcriptional profile 146 in BLCs and PBMCs 147
To first assess transcriptome-wide differences between compartments, we used RNA-seq to 148 determine RNA expression differences between BLCs and PBMCs in four HIV-uninfected 149 participants and three HIV-infected participants from the hospital-based cohort. Except for sample after deduplication (Supplementary figure 2) . 152
There were 4,761 differentially expressed genes (DEGs) between the BLCs and PBMCs in 153 either HIV-positive or HIV-negative participants. Of these, there were 4,084 DEGs between 154
BLCs and PBMCs in the HIV-negative group, with 2,336 genes being upregulated and 1,748 155 genes being downregulated in BLCs when compared with PBMCs ( Figure 2A ). On the other 156 hand, there were 2,186 DEGs between BLCs and PBMCs in the HIV-positive group, with 157 1,204 genes being upregulated and 982 genes being downregulated in BLCs when compared 158 with PBMCs ( Figure 2B ). Notably, the large majority of the DEGs (69% (1,509 out of 159 2,186)) between compartments in the HIV-positive individuals were also differentially 160 expressed between compartments in the HIV-negative individuals ( Figure 2C ). 161
To assess the compartment-specific effects of HIV, we then checked for differences between 162 the HIV-negative and HIV-positive groups within each compartment. There were 774 DEGs 163 in PBMCs between the HIV-positive and the HIV-negative groups, with 515 genes being 164 upregulated and 259 genes being downregulated in the HIV-positive group ( Figure 2D ). On 165 the other hand, there were 727 DEGs in BLCs in comparisons between the HIV-positive 166 group and the HIV-negative group, with 540 genes being upregulated and 187 genes being 167 downregulated in the HIV-positive group ( Figure 2E ). Notably, of the DEGs in either the 168 BLCs or the PBMCs between disease states, only a very small minority (6.9%, 97 of 1401) 169 were differentially expressed in both compartments. Thus, HIV-induced transcriptional 170 alterations were compartment-specific ( Figure 2F ). 171
Using gene ontology (GO) analyses to annotate enriched functions in these compartment 172 specific HIV-induced transcriptional changes, we identified 30 GO terms that were 173 significantly enriched (FDR q-value<0.05) in our list of DEGs in PBMCs between the HIV-significantly enriched GO terms in BLCs between the HIV-positive and HIV-negative groups 176 (Supplementary table 3 ). The top enriched GO term in the PBMCs of HIV-positive 177 participants was the "type I interferon signaling pathway" gene set ( Figure 3A ). On the other 178 hand, the most enriched GO term in the BLCs of HIV-positive participants was the "adaptive 179 immune response" gene set ( Figure 3B ). We also observed some enrichment of the "response 180 to interferon-beta" and "type I interferon signaling pathway" GO terms in the BLCs of HIV-181 positive participants, but those GO terms ranked low in our list ( Supplementary table 3) . 182
Thus, even though HIV also induces a type I interferon signaling signature in 183 bronchoalveolar compartment, its dominant effect there is the modulation of adaptive 184 immune responses. 185
Enrichment of the "type I interferon signaling pathway" gene set in HIV-positive PBMCs 186 was due to upregulation of twenty genes, namely EGR1, IFI27, IFI35, IFI6, IFIT1, IFIT2, 187 IFIT3, IFITM3, IRF4, IRF7, ISG15, MX1, MX2, OAS1, OAS2, OAS3, OASL, STAT1, XAF1 188 and RSAD2. On the other hand, enrichments of the "type I interferon signaling pathway" and 189 the "response to interferon-beta" gene sets in HIV-positive BLCs were due to upregulation of 190 fourteen genes, namely EGR1, IFITM1, IFITM2, IFITM3, IRF1, IRF3, IRF4, IRF7, ISG15, 191 ISG20, RSAD2, AIM2, CDC34 and PYHIN1 ( Figure 3C ). Notably, from the above lists of 192 twenty-eight type I interferon-associated genes that were differentially expressed in either of 193 the two compartments, only six (namely EGR1, IFITM3, IRF4, IRF7, ISG15, and RSAD2) 194 were differentially expressed in both compartments, suggesting qualitative differences 195 between the compartments. 196
In BLCs, enrichment of the "adaptive immune response" gene set was attributable to the 197 HIV-induced upregulation of transcripts that suggested infiltration with cytolytic T cells, 198 such as the lineage transcripts for CD8 + T cells (CD3D, CD3E, CD3G, CD8A and CD8B), 199 gamma (IFNG)) and the CD8 + T-cell transcription factors (e.g. EOMES) ( Figure 3C ). We 201 also observed contribution by inhibitory/exhaustion markers (PD-1 (PDCD1) and LAG-3 202 (LAG3)) in the enrichment of this GO term. Further observation of B-cell transcripts (CD19, 203 CD79A and CD79B) suggests that HIV also induces infiltration of the bronchoalveolar 204 compartment by other lymphocytes as previously reported 15 ( Figure 3C ). 205
Since the GO analyses suggested lymphocyte infiltration into the bronchoalveolar 206 compartment, we conducted further targeted analyses on the major lymphocyte lineage 207 markers to determine the infiltrating populations. There were significant upregulations of 208 were not significantly altered in BLCs, suggesting that the upregulation of cytotoxic markers 214 in the BLCs of HIV-positive patients could be attributed to infiltration by cytotoxic CD8 + T 215 cells and not natural killer cells (Supplementary 3G). The levels of CD4 transcripts did not 216 differ between disease states in either of the compartments, probably because the molecule is 217 expressed on CD4 + T cells as well as other lineages such as monocytes and macrophages, a 218 phenomenon that could mask the known HIV-induced CD4 + T-cell depletion (Supplementary 219 3H), with the latter confirmed by flow cytometry in PBMCs ( Figure 1E ). 220
The whole compartment transcriptomic approach limited our ability to confidently attribute 221 the transcripts of effector molecules to any specific cell type, and in particular the infiltrating 222 CD8 + T cell population which appeared the most likely candidate based on transcriptome 223 cytometry and RNA-seq on sorted CD8 + T cells. At the protein level, HIV-positive people 225 had higher levels of constitutive Granzyme B production in both PBMCs-derived and BLCs-226 derived CD8 + T cells ( Figure 4A ). However, ex vivo stimulation with mitogens yielded 227 similar inducible interferon gamma between the disease states in both PBMCs-derived and 228
BLCs-derived CD8 + T cells ( Figure 4B ). In agreement with our analyses on bulk BLCs, the 229 HIV-positive individuals had increased expression of PD-1 in BLCs-derived CD8 + T cells 230 when compared with HIV-negative individuals ( Figure 4C ). Similar trends on PD-1 231 expression were seen when we analyzed the two cohorts separately, confirming that they 232 were immunologically similar (Supplementary figure 4 C and F). Transcriptional analysis of 233 mRNA levels from sorted CD8 + T cells confirmed these findings. HIV was associated with a 234 trend of increased transcription for granzyme B (GZMB) in BLC-derived CD8 + T cells 235 ( Figure 4D ). Unlike the observation on inducible interferon gamma protein, we observed 236 trends of higher constitutive expression of IFNG in HIV-positive individuals in both PBMCs-237 derived and BLCs-derived CD8 + T cells, suggesting that HIV infection could be associated 238 with increased constitutive transcription of IFNG in vivo ( Figure 4E ). In agreement with the 239 data on expression of PD-1 protein on CD8 + T cells, we observed a trend of HIV-associated 240 increase in transcription of the PD-1 (PDCD1) in both BLCs-derived and PBMCs-derived 241 CD8 + T cells ( Figure 4F ). Thus, the infiltrating CD8+ T cells in HIV-positive individuals' 242 bronchoalveolar compartment had a functional phenotype consistent with pre-existing 243 cytotoxic products. Considering that PD-1 can be a marker of both exhaustion and activation 244 depending on context, the significance of increased PD-1 expression in BLC-derived CD8 T 245 cells in the HIV-positive group needs to be determined in future studies. 246 247 Discussion 248 morbidities 13, 16, 17 . HIV-positive patients have a higher prevalence of Pneumocystis 250 pneumonia, active tuberculosis, bacterial pneumonia and viral pneumonia 13, 16 . They also 251 have a higher prevalence of noninfectious structural lung complications such as emphysema 252 and chronic obstructive pulmonary disease (COPD) 13, 17 . 253
Despite the high prevalence of HIV-induced lung complications, the immunopathogenesis of 254 HIV in the lung is poorly understood. Due to logistical difficulties of obtaining lung samples, 255 most studies on immune responses to respiratory infections have been conducted in 256 peripheral blood with an assumption that circulating cells have similarities with those in the 257 lung. Here, we show that there are significant differences in the global transcriptional profiles 258 between the blood and the bronchoalveolar compartment, and that the immunological effects 259 of HIV infection revealed by whole compartment transcriptomics in the two compartments 260 are different. 261
While a type I interferon signature was the most dominant effect of HIV in PBMCs, a CD8 + 262 T-cell infiltrate was the dominant effect in the bronchoalveolar compartment. We also 263 observed a weaker and qualitatively different HIV-associated type I interferon signature in 264 the bronchoalveolar compartment of viremic HIV patients. An elevated interferon signature 265 in blood has been associated with progression to TB disease and could arguably relate to the 266 increased susceptibility to TB disease among HIV patients who have a strong type I 267 interferon signature in blood 10 . The qualitative differences in type I interferon signatures 268 between the compartments could be due to the differences in cellular compositions. Whether 269 specific lung signatures drive the association of type I interferon signaling with progression 270 from latent to active TB remains largely unknown and can be addressed through the study of 271 the bronchoalveolar compartment in participants who go on to develop TB disease. 272 cells has been reported in previous studies. However, there is limited information on its 274 functional nature 15, 18 . Using both flow cytometry and whole compartment and CD8 + T cell 275 specific RNA-seq, we show that the HIV-induced CD8 + T-cell infiltrate is associated with 276 higher expression of effector molecules such as granzymes, perforin and interferon gamma, 277 suggesting a cytolytic and inflammatory profile. We also report higher expression of PD-1 on 278 bronchoalveolar CD8 + T cells of HIV-positive patients. PD-1 expression in CD8 + T cells has 279 been associated with exhaustion 19 . However, in juvenile idiopathic arthritis, PD-1 + CD8 + T 280 cells derived from synovial fluid were metabolically active functional effector memory T 281 cells, suggesting that PD-1 expression could also act as a marker of locally adapted functional 282 T cells 20 . Thus, depending on context, PD-1 could be a marker of either exhaustion or local 283 activation in tissues. Even though PD-1 blockade on BLCs-derived T cells from HIV-positive 284 patients was previously shown to boost cytokine secretion in vitro, suggesting exhaustion, 285 there was a counterintuitive increased PD-1 expression among the interferon gamma 286 secreting T cells 18 . As such, the implication of HIV-associated increase in PD-1 expression 287 on CD8 + T cells in the bronchoalveolar compartment needs further investigation. 288
The HIV-induced infiltration of the bronchoalveolar compartment with cytolytic CD8 + T 289 cells could be driven directly by HIV replication 21 . The lung has been shown to be a site of 290 HIV replication where small alveolar macrophages and CCR5 expressing CD4 + T cells are 291 preferentially infected with HIV 9, 22 . Infiltrating CD8 + T cells could control local HIV 292 replication by killing the HIV-infected CD4 + T cells and alveolar macrophages. Indeed, in 293 previous studies, lymphocytic alveolitis in asymptomatic HIV patients was enriched for HIV-294 specific cytotoxic CD8 + T cells that could execute such effector functions 18 . Whether HIV 295 induces bronchoalveolar infiltration with other specificities of CD8 + T cells that can 296 modulate opportunistic respiratory infections, such as tuberculosis, is unclear. noninfectious lung complications, such as COPD and emphysema. Considering that HIV 299 infection is also associated with increased prevalence of the same noninfectious lung 300 complications, HIV-induced lymphocytic alveolitis is thought to accelerate the deterioration 301 of lung function in patients who are exposed to other risk factors for COPD and emphysema, 302 such as smokers 21, [23] [24] [25] [26] Mycobacterium tuberculosis in granulomas thus promoting bacterial dissemination. Notably, 313 the CD8 + T-cell infiltrate in our cohorts was characterized by increased expression of 314 granzymes and perforin, suggesting some overlap between the findings in our cohorts and the 315 Leishmania major mouse model 28 . Additional studies will be needed to directly interrogate 316 the possible contribution of infiltrating CD8 + T cells in the inflammatory destruction of lung 317 tissues and the anatomical dissemination of Mycobacterium tuberculosis infections. 318
We conclude that HIV is associated with a cytolytic CD8 + T-cell infiltrate in the 319 bronchoalveolar compartment. Further mechanistic studies are required to understand the 320 consequences of the infiltration on respiratory infections, such as Mycobacterium suggested an enrichment for HIV-specific CD8 + T cells 18 . In future studies, it will be 324 important to determine whether enrichment for CD8 + T cells against respiratory infections, 325 such as Mycobacterium tuberculosis occurs, and the functional competence of these cell. This 326 study was limited by the sample size in the transcriptomic profiling and intracellular cytokine 327 staining. Nevertheless, the data reveal important compartment-specific effects of HIV in the 328 bronchoalveolar compartment, suggesting a possible mechanism by which HIV modulates 329 immunity to respiratory infections and lung function in ways that cannot be revealed by 330 studying peripheral blood. Furthermore, we show the utility of using whole compartment 331 transcriptomic analyses to reveal infiltration of different sites with various immune cells. 332
Methods 333
Study population 334
We studied the effect of HIV on immune function in the peripheral blood and 335 bronchoalveolar compartment using two bronchoalveolar study cohorts at African Health 336
Research Institute (AHRI) in KwaZulu-Natal, South Africa. The first cohort was a hospital-337 based cohort in which we recruited HIV-negative or HIV-positive ART-naive participants 338 Freshly processed cellular pellets from bronchoalveolar lavage (1 mL of BAL fluid) and 396
Histopaque gradient-isolated PBMCs (1 X 10 6 cells) from the hospital cohort for bulk were later thawed at room temperature, pelleted and suspended with 1% β -mercaptoethanol 399 RLT buffer from the Qiagen RNeasy Micro kit (Qiagen, Hilden, Germany). Extraction of 400 RNA was performed according to manufacturer's protocol. Briefly, a QIAshredder column 401 was used to homogenize the samples. DNAse 1 treatment was used to eliminate any 402 remaining genomic DNA contamination. The extracted RNA was quantified using nanodrop 403 and aliquoted into ~200 ng aliquots, adequate for RNASeq library preparation. All aliquots 404
were immediately stored at -80 0 C. 405 406
Sorted CD8+ T cell populations 407
For work on purified CD8 + T cells, freshly processed cells from the hospital cohort were 408 sorted into 70% TRIzol LS Reagent (Thermo Fisher Scientific, Waltham, MA, USA) and 409 stored at -80 0 C. Both RNA and DNA were isolated from these samples using the 410 TRIzol/chloroform method with minor modifications. Briefly, RNA was precipitated using a 411 nucleic acid co-precipitant, 5 mg/mL linear acrylamide (Thermo Fisher Scientific). All 412 reagents were kept at 4 0 C to facilitate separation of nucleic acid into different layers and 413 efficient precipitation. QIAGEN RNeasy Micro kit was used to purify RNA from the TRIzol 414 The raw data were demultiplexed and processed using Trimmomatic version 0.36 to remove 430 adaptors and leading/trailing low-quality bases. Subsequent analyses were done using the 431 Tuxedo protocol as previously described 29 . Briefly, the sequences were aligned on the 432 human reference genome GRCh37 (hg19) using the TopHat module (version 2.1.1) and 433 bowtie (version 2.2.4). The mapped reads were then sorted using the Picard SortSam module. 434
Duplicate reads were identified using the Picard MarkDuplicates module and removed. The 435 Cufflinks module (Version 2.2.1) was used for subsequent analyses. The transcripts for each 436 sample were assembled and the numbers of reads quantified for each transcript. The 437 expression levels were expressed as Fragments Per Kilobase of transcript per Million 438 fragments mapped (FPKM). The assembled transcripts for all samples were merged to obtain 439 a master transcriptome assembly (Cuffmerge) followed by assessment of differential 440 expression (Cuffdiff). A statistically significant difference in the expression of a transcript 441 between two groups of participants was defined as having at least a two-fold difference and q 442 < 0.05 (after Benjamini-Hochberg correction for multiple-testing). CummeRbund R package 443 (version 2.16), GraphPad Prism (version 8) and Morpheus-Broad Institute 444 (https://software.broadinstitute.org/morpheus/) were used for subsequent data visualization. gorilla.cs.technion.ac.il/) by checking for enriched Gene Ontology (GO) terms among the 447 differentially expressed genes 30 . To exclude very large or very small nonspecific GO terms 448 that did not have specific biological implications, an arbitrary cut-off was set whereby only 449 GO terms whose sizes are between 20 and 200 genes were considered in the analyses. 
